See All Slides -

Slides

Presentation TCT 2016

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

How to Be a Key Investigator? Its Not Just Quantity- Quality Is Top Priority

Presenter: David A. Cox, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Medical Management of Non-Obstructive HCM: When and Which Medications?

Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Radial Access in ACS: Case Closed?

Presenter: Francesco Burzotta, Sunil V. Rao, Davide Capodanno

October 30, 2016

Presentation TCT 2016

Case Reviews: Transradial Approach in Complex Coronary Lesions

Presenter: Georgios Sianos, Sasko Kedev

October 30, 2016

Presentation TCT 2016

Whats Next for the Nurse/Tech Team?

Presenter: Regina Deible, Mary K. Egan

October 30, 2016

Presentation TCT 2016

FDA Perspectives

Presenter: Elazer R. Edelman, Juan F. Granada, Changfu Wu

October 30, 2016

Presentation TCT 2016

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials

Presenter: Roxana Mehran, Pascal Vranckx, Robert A. Harrington

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Xience Cobalt Chromium Fluoropolymer-Based Everolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Tullio Palmerini

October 30, 2016

Advertisement

Slides

Role of LAA in Atrial Arrhythmias: Origin and Maintenance

How to Be a Key Investigator? Its Not Just Quantity- Quality Is Top Priority

Medical Management of Non-Obstructive HCM: When and Which Medications?

Radial Access in ACS: Case Closed?

Case Reviews: Transradial Approach in Complex Coronary Lesions

Whats Next for the Nurse/Tech Team?

FDA Perspectives

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR

Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials

Stent Design and Comprehensive Data Review: Xience Cobalt Chromium Fluoropolymer-Based Everolimus-Eluting Stents

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content